Endogenex has shared results from its REGENT-1 clinical study during the Digestive Disease Week (DDW) 2025 event held in San ...

Inquis Medical has reported that the trial of its Aventus thrombectomy system for pulmonary embolism (PE) met its primary ...

Core has completed the acquisition of neurotechnology solution provider NeuroMetrix, including its Quell platform.

Neurogen Biomarking has announced a collaboration with NeuroX to support patients’ journey on its brain health care ecosystem ...

The FDA designation is a step forward for Neuralink as owner Elon Musk faces increasing scrutiny. The US Food and Drug ...

Canada’s UHN and U of T researchers have created a skin-based test that identifies progressive supranuclear palsy (PSP) ...

A baby has been born following an AI-automated in vitro fertilisation (IVF) procedure conducted remotely by engineers and ...

The US FDA has approved Element Science’s premarket approval (PMA) application for its Jewel Patch Wearable Cardioverter ...

The London Cancer Hub has been identified as a key district for ‘frontier innovation’ by London Mayor Sadiq Khan.

The US Food and Drug Administration (FDA) has cleared OcuSciences’ retinal health assessment device, the OcuMet Beacon.

SafeHeal has pulled in €35m ($39.7m) in Series C equity financing to validate its Colovac endoluminal bypass system.

LuxIA, an AI algorithm co-developed by RetinAI US and FVS, has achieved CE-MDR certification for diabetic retinopathy (DR) ...